Results 261 to 270 of about 85,906 (293)
Some of the next articles are maybe not open access.

Technetium-99m Diphosphonate Retention in Hyperparathyroidism

Annals of Internal Medicine, 1980
Excerpt To the editor: Fogelman and colleagues (1) show increased total-body retention of technetium-99m diphosphonate in a small group of patients with primary hyperparathyroidism and equate this ...
openaire   +2 more sources

Scintimammography with technetium-99m tetrofosmin

European Journal of Nuclear Medicine, 1996
MANSI, Luigi, RAMBALDI PF
openaire   +3 more sources

SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997
Technetium-99m-HMPAO and 99mTc-ECD have been used for regional cerebral blood flow (rCBF) studies using SPECT. However, details of the normal perfusion patterns of these agents still remain to be clarified. HMPAO-SPECT and ECD-SPECT images of normal individuals were investigated using an anatomical standardization technique.Twenty healthy subjects ...
M, Koyama   +9 more
openaire   +1 more source

Addressing Technetium-99m Shortage

Journal of the American College of Radiology, 2017
Mahadevappa Mahesh, Mark Madsen
openaire   +2 more sources

The Radiopharmaceutical Chemistry of Technetium-99m

Radiopharmaceutical Chemistry, 2019
S. Rathmann   +5 more
semanticscholar   +1 more source

Technetium-99m radiochemistry for pharmaceutical applications.

Journal of labelled compounds & radiopharmaceuticals, 2017
D. Papagiannopoulou
semanticscholar   +1 more source

Scanning the thyroid with technetium-99m-pertechnetate.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992
PubMed ID ...
Ozkilic, H, Derebek, E
openaire   +2 more sources

Purification-Free Method for Preparing Technetium-99m-Labeled Multivalent Probes for Enhanced in Vivo Imaging of Saturable Systems.

Journal of Medicinal Chemistry, 2016
Yuki Mizuno   +5 more
semanticscholar   +1 more source

Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997
Technetium-99m-MIBI was initially developed for heart studies but it can also be used to depict tumors, predict multidrug resistance and evaluate chemotherapy. Recently, 99mTc-tetrofosmin, which exhibits similar physical properties, has been launched for heart studies.
V, Söderlund   +4 more
openaire   +1 more source

A review on evaluation of technetium-99m labeled radiopharmaceuticals

Journal of Radioanalytical and Nuclear Chemistry, 2016
M. Akbar   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy